Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00600769 · ClinicalTrials.gov registry record · Phase 4
Clarithromycin for the Treatment of Infections Caused by Nontuberculous Mycobacteria (NTM)
A Phase 4 study of Nontuberculous Mycobacteria and Mycobacterium Avium Complex, sponsored by The University of Texas Health Science Center at Tyler.
- Completed
- Registry status
- Phase 4
- Development phase
- 210
- Enrollment target
- 1
- Study location
NCT00600769: Completed Phase 4 study of Nontuberculous Mycobacteria and Mycobacterium Avium Complex, sponsored by The University of Texas Health Science Center at Tyler.
NCT00600769 is a Phase 4 study of Nontuberculous Mycobacteria and Mycobacterium Avium Complex that has completed, run by The University of Texas Health Science Center at Tyler. The registered enrollment target is 210 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00600769, a Phase 4 study of Nontuberculous Mycobacteria and Mycobacterium Avium Complex, has completed, sponsored by The University of Texas Health Science Center at Tyler.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 210 participants
- Enrollment target
- 1
- Study location
Study Summary
Use of oral clarithromycin for treatment of chronic lung disease due to Mycobacterium avium-intracellulare and other non-tuberculous Mycobacteria
Primary Outcome
neg culture x3( sputum conversion)
Conditions Studied
Interventions
- DRUG Clarithromycin
Study Locations (1)
Texas
- The University of Texas Health Science Center at Tyler - Tyler
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 210 participants |
| Start Date | 1991-01 |
| Est. Completion | 2017-05-18 |
| Phase | Phase 4 |
What the finished NCT00600769 record still lists
NCT00600769 is an interventional study that assigns participants to a tested intervention. The registered 210 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (59% lower).
The record links to 2 conditions, with Nontuberculous Mycobacteria appearing as the primary indexed condition, and to 1 intervention - of which Clarithromycin is the first listed.
NCT00600769 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT00600769 about?
NCT00600769 is a clinical study titled "Clarithromycin for the Treatment of Infections Caused by Nontuberculous Mycobacteria (NTM)". Use of oral clarithromycin for treatment of chronic lung disease due to Mycobacterium avium-intracellulare and other non-tuberculous Mycobacteria
What is the current status of trial NCT00600769?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 210 participants. The study started on 1991-01. Estimated completion is 2017-05-18.
What conditions does trial NCT00600769 study?
This clinical trial studies the following conditions: Nontuberculous Mycobacteria, Mycobacterium Avium Complex.
What interventions are being tested in trial NCT00600769?
The interventions under investigation include: Clarithromycin (DRUG).
Who is sponsoring clinical trial NCT00600769?
This trial is sponsored by The University of Texas Health Science Center at Tyler, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00600769 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nontuberculous Mycobacteria
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00600769's enrollment target sits among peer trials
210 398th of 2000 higher than 1,603 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02665923 · 210 participants
Gastric Emptying in Neonates and Infants After Formula Feeding
- NCT03322891 · 210 participants · NA
Improving Health Literacy in African-American Prostate Cancer Patients
- NCT03544489 · 210 participants · Phase 2
Effectiveness of Exercise After an ICD
- NCT04408430 · 210 participants · NA
The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia